New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on: October 31,2023 12

New antibody may offer effective drug treatment for breast cancer

An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas Tonks. With further development, the antibody

Updated on:October 31,2023 12

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra

Updated on: January 08,2024 10

Why start mammograms at 40? Doctor explains new advice

by Samantha Laine Perfas,Harvard UniversityCredit: Unsplash/CC0 Public DomainWomen should start getting regular mammograms at the age of 40, according toa new recommendationbeing dra

Updated on:January 08,2024 10

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on: October 31,2023 27

New insight into BRCA2 gene mutations and cancer risk

A recent study from researchers at the University of California examines the BRCA2 gene, which plays a crucial role in repairing damaged DNA, and possible links with increased risk of breast and ovari

Updated on:October 31,2023 27

Impact of epigenetics on the clinical management of cancer patients

byJosep Carreras Leukaemia Research InstituteClinical applications of epigenetic biomarkers. Cancer specificity of the epigenetic profiles generated not only from tumor tissues (solid biopsies)

Updated on: December 19,2023 10

Impact of epigenetics on the clinical management of cancer patients

byJosep Carreras Leukaemia Research InstituteClinical applications of epigenetic biomarkers. Cancer specificity of the epigenetic profiles generated not only from tumor tissues (solid biopsies)

Updated on:December 19,2023 10

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig

Updated on: October 31,2023 2

Study finds carcinogen exposure makes cancer cells more susceptible to immune attack

by Liz Murphy,Massachusetts General HospitalCarcinogen-exposed cancer cells transform that nature of tumor-infiltrating macrophages from immunosuppressive (left) to immune activating agents (rig

Updated on:October 31,2023 2

Discovery New Biomarker for Cancer Stem Cells

Protein Linked to Tumor Survival and SpreadByLaurie Fickman713-743-8454n the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnor

Updated on: October 31,2023 22

Discovery New Biomarker for Cancer Stem Cells

Protein Linked to Tumor Survival and SpreadByLaurie Fickman713-743-8454n the world of cancer biology, not all biomarkers are created equal. These molecules that alert doctors that an abnor

Updated on:October 31,2023 22

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on: October 31,2023 10

NCCN releases new resources to improve quality of life for people with cancer

The National Comprehensive Cancer Network®(NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual need

Updated on:October 31,2023 10

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t

Updated on: January 08,2024 8

Why does a leukemic mutation not always lead to leukemia? A new clue from a mouse study

byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainWhy do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop t

Updated on:January 08,2024 8

Corrupt endothelial cells found to protect blood cancer cells from chemotherapy

byWeill Cornell Medical CollegePatient-derived-tumor-xenograft (PDX) as models of high-risk T-ALL patients. (A) Schematic representation of the generation and expansion of T-ALL PDX models. PB:

Updated on: December 21,2023 8

Corrupt endothelial cells found to protect blood cancer cells from chemotherapy

byWeill Cornell Medical CollegePatient-derived-tumor-xenograft (PDX) as models of high-risk T-ALL patients. (A) Schematic representation of the generation and expansion of T-ALL PDX models. PB:

Updated on:December 21,2023 8

Radiotherapy for hard-to-treat bladder cancer

byInstitute of Cancer ResearchCredit: Institute of Cancer ResearchMore targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis, acco

Updated on: December 20,2023 16

Radiotherapy for hard-to-treat bladder cancer

byInstitute of Cancer ResearchCredit: Institute of Cancer ResearchMore targeted forms of radiotherapy can effectively treat bladder cancer which has spread to the lymph nodes of the pelvis, acco

Updated on:December 20,2023 16

Researchers identify 'switch' to activate cancer cell death

byUC DavisAntigen-positive tumor cell (blue, left) is a direct target of CAR T-cells (light red) due to high-affinity antibody-antigen contacts. On the contrary, an antigen-negative tumor cell (

Updated on: October 31,2023 5

Researchers identify 'switch' to activate cancer cell death

byUC DavisAntigen-positive tumor cell (blue, left) is a direct target of CAR T-cells (light red) due to high-affinity antibody-antigen contacts. On the contrary, an antigen-negative tumor cell (

Updated on:October 31,2023 5

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on: October 11,2023 258

Intensity of Consolidation Pre-Transplant Shows No Difference in Outcomes in Older AML

September 7, 2023Caroline SeymourNo difference in relapse-free survival or non–relapse mortality was seen with intensive vs non-intensive consolidation chemotherapy regimens prior to allogeneic hemato

Updated on:October 11,2023 258